Fouzia Laghrissi-Thode - 03 Jun 2026 Form 4 Insider Report for Minerva Neurosciences, Inc. (NERV)

Reporting relationship: Director
Issuer ticker: NERV
Reported as of: 03 Jun 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Jun 2026, 18:00:13 UTC
Prior SEC filing: 23 Dec 2025
Source filing: View source filing
Reporting owner signature: /s/ Frederick Ahlholm, Attorney-in-Fact

Key filing fact

Fouzia Laghrissi-Thode filed Form 4 for Minerva Neurosciences, Inc. (NERV) on 05 Jun 2026.

Key facts

This page summarizes Fouzia Laghrissi-Thode's Form 4 filing for Minerva Neurosciences, Inc. (NERV).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 05 Jun 2026, 18:00.

Change

Previous filing in this sequence was filed on 23 Dec 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001642015 Primary reporting owner

Laghrissi-Thode Fouzia

Relationship: Director
Address: C/O MINERVA NEUROSCIENCES, INC.,, 1500 DISTRICT AVENUE, BURLINGTON
Signature: /s/ Frederick Ahlholm, Attorney-in-Fact
Signature date: 05 Jun 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NERV transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +50,000
Change %
Price: $0.000000^*
Shares after: 50,000
Date: 03 Jun 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $4.68
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to this option vest in four equal quarterly installments at a rate of 1/4 of the total number of shares every three months, with the first 1/4 vesting on the date that is three months following June 3, 2026 and an additional 1/4 vesting every three months thereafter, subject in each case to the continued service of the Reporting Person as a non-employee director as of such vesting date.